• 
  Faten Merhi, Karla Alvarez-Valadez, Jenifer Trepiana, Claire Lescoat, Alexis Groppi, et al.. Targeting CAMKK2 and SOC Channels as a Novel Therapeutic Approach for Sensitizing Acute Promyelocytic Leukemia Cells to All-Trans Retinoic Acid. Cells, 2021, 10 (12), pp.3364. ⟨10.3390/cells10123364⟩. ⟨hal-03457279⟩
• 
  Giuseppe Arena, Madi Yann Cisse, Samuel Pyrdziak, Laurent Chatre, Romain Riscal, et al.. Mitochondrial MDM2 regulates respiratory complex i activity independently of p53. Molecular Cell, 2018, 69 (4), pp.594-609. ⟨10.1016/j.molcel.2018.01.023⟩. ⟨hal-01837662⟩
• 
  Aygun Imanci. L'implication des suppresseurs de tumeur, TET2 et TP53, dans l'évolution et le traitement de la Leucémie myélomonocytaire Chronique. Cancer. Université Paris-Saclay, 2023. Français. ⟨NNT : 2023UPASL113⟩. ⟨tel-04485463⟩
• 
  Pascal-Alexandre Thomas, Anne-Laure Couderc, David Boulate, Laurent Greillier, Aude Charvet, et al.. Early-stage non-small cell lung cancer beyond life expectancy: Still not too old for surgery?. Lung Cancer, 2021, 152, pp.86-93. ⟨10.1016/j.lungcan.2020.12.009⟩. ⟨hal-03526487⟩
• 
  Dorian Culié, Quentin Lisan, Charlotte Leroy, Anouchka Modesto, Renaud Schiappa, et al.. Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study. European journal of cancer, 1970, 143, pp.168-177. ⟨10.1016/j.ejca.2020.10.034⟩. ⟨hal-03618860⟩
• 
  Jean-Emmanuel Kurtz, Xavier Buy, Frédéric Deschamps, Erik Sauleau, Amine Bouhamama, et al.. CRYODESMO-O1: A prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. European Journal of Cancer, 2021, 143, pp.78-87. ⟨10.1016/j.ejca.2020.10.035⟩. ⟨hal-03623642⟩
• 
  Sylvain Manfredi, Anthony Turpin, David Malka, Emilie Barbier, Pierre Laurent-Puig, et al.. Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III study. Digestive and Liver Disease, 2020, 52 (10), pp.1143-1147. ⟨10.1016/j.dld.2020.06.034⟩. ⟨hal-04548048⟩
• 
  Sarah Atallah, Odile Casiraghi, Nicolas Fakhry, Michel Wassef, Emmanuelle Uro-Coste, et al.. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors. European journal of cancer, 2020, 130, pp.241-249. ⟨10.1016/j.ejca.2020.01.023⟩. ⟨hal-03599053⟩
• 
  F. Mosele, B. Stefanovska, A. Lusque, A. Tran Dien, I. Garberis, et al.. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer. Annals of Oncology, 2020, 31 (3), pp.377-386. ⟨10.1016/j.annonc.2019.11.006⟩. ⟨hal-04522293⟩
• 
  Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray-Coquard, Axel Le Cesne, et al.. A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib. European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩. ⟨hal-03623680⟩
• 
  Manuel Rigon, Luciano Mutti, Michelangelo Campanella. Pleural mesothelioma ( PMe ): The evolving molecular knowledge of a rare and aggressive cancer. Molecular Oncology, 2024, 18 (4), pp.797-814. ⟨10.1002/1878-0261.13591⟩. ⟨hal-04798641⟩
• 
  Bertrand Routy, Lisa Derosa, Laurence Zitvogel, Guido Kroemer. COVID-19: a challenge for oncology services. OncoImmunology, 2020, 9 (1), ⟨10.1080/2162402X.2020.1760686⟩. ⟨hal-03150177⟩
• 
  Sissel Dyrstad, Maria Lotsberg, Tuan Zea Tan, Ina Pettersen, Silje Hjellbrekke, et al.. Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells. Cancers, 2021, 13 (5), pp.941. ⟨10.3390/cancers13050941⟩. ⟨hal-03434234⟩
• 
  Lionel Perrier, Pauline Rascle, Magali Morelle, Maud Toulmonde, Dominique Ranchere Vince, et al.. The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group. PLoS ONE, 2018, 13 (4), pp.e0193330. ⟨10.1371/journal.pone.0193330⟩. ⟨halshs-01784301⟩
• 
  Francois Gouin, Audrey Michot, Mehrdad Jafari, Charles Honoré, Jean Camille Mattei, et al.. Improved metastatic-free survival after systematic re-excision following complete macroscopic unplanned excision of limb or trunk soft tissue sarcoma. Cancers, 2024, 16 (7), pp.1365. ⟨10.3390/cancers16071365⟩. ⟨hal-04653665⟩
• 
  E. Felip, B. C. Cho, V. Gutiérrez, A. Alip, B. Besse, et al.. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA. Annals of Oncology, 2024, 35 (9), pp.805-816. ⟨10.1016/j.annonc.2024.05.541⟩. ⟨hal-04724689⟩
• 
  Mehdi Latiri, Charlotte Smith, Estelle Balducci, Antoine Pinton, Guillaume P. Andrieu, et al.. DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymoma. Journal of Pathology, 2024, ⟨10.1002/path.6346⟩. ⟨hal-04724663⟩
• 
  María-Jesús Lobón-Iglesias, Mamy Andrianteranagna, Zhi-Yan Han, Céline Chauvin, Julien Masliah-Planchon, et al.. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups. Nature Communications, 2023, 14 (1), pp.6669. ⟨10.1038/s41467-023-42371-7⟩. ⟨hal-04295076⟩
• 
  C. B. Westphalen, D. Martins-Branco, G. Pentheroudakis, J. R. Beal, C. Cardone, et al.. The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development. Annals of Oncology, 2024, ⟨10.1016/j.annonc.2024.07.730⟩. ⟨hal-04724604⟩
• 
  Maria M Haykal, Sylvie Rodrigues-Ferreira, Clara Nahmias. WEE1 kinase inhibition triggers severe chromosome pulverization in aneuploid cells. 2024. ⟨hal-04746752⟩

2 543

2 548